Skip to main content

Characterisation of a novel #chicken-derived #H3N3 avian #influenza virus detected in #China in 2023: Pathogenicity and immunogenicity

 


Abstract

The poultry industry faces a constant threat from the mutation and transmission of avian influenza viruses (AIVs). While waterfowl and wild birds are natural hosts of H3N3 AIV, reports of H3N3 infections in chickens are limited. However, in 2023, a decline in egg production among laying hens in the Yancheng Region of Jiangsu Province prompted a study. This research aimed to diagnose the aetiology in laying hens through molecular virological methods and characterise the biological properties of the causative pathogens. An H3N3 AIV subtype strain, A/chicken/China/YC01/2023(H3N3), was isolated from chickens exhibiting lesions. Genome sequencing and analysis revealed a novel genetic makeup: the HA gene originated from an H3N8 AIV, the NA gene from an H10N3 AIV, and the internal genes from an H9N2 AIV, all circulating in China. Chickens experimentally infected with the isolate showed signs of Harderian gland haemorrhage, nasal mucus, tracheal circumferential bleeding, and lung bleeding and localised necrosis. Histopathological examination confirmed nasal mucosal and tracheal inflammation, lung capillary congestion, liver cell damage, and sparse splenic lymphocytes. Viral shedding was significantly higher in the oropharyngeal cavity, peaking 2–6 days post-infection, compared to the cloaca. For the first time, the immunogenicity of a novel chicken-derived H3N3 subtype AIV was assessed in specific pathogen-free chickens. An inactivated vaccine, prepared from the isolated strain, resulted in antibody titres peaking at 9.6 log2 four weeks after immunization. Furthermore, challenges with either the isolated strain or a duck-origin BZ01/2023(H3N3) strain after immunisation did not cause clinical signs or viral shedding on day 4. In conclusion, the isolate H3N3 AIV can replicate in chickens, leading to organ damage and pathogenicity. Crucially, the inactivated vaccine derived from this isolate is highly immunogenic and provides cross-protection against the duck-derived strain.

Source: PLoS One, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0332213

____

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...